0Log in
(210414) -- ANKARA, April 14, 2021 -- A woman receives the COVID-19 vaccine in Ankara, Turkey, on April 14, 2021. Turkey confirmed 62,797 more novel coronavirus cases on Wednesday, its highest single-day figure since the start of the pandemic. Among the new cases are 2,802 symptomatic patients, and the total number in the country has reached 4,025,557, according to the Turkish Health Ministry. (Photo by Xinhua) TURKEY-ANKARA-COVID-19-CASES MustafaxKaya

(210414) -- ANKARA, April 14, 2021 -- A woman receives the COVID-19 vaccine in Ankara, Turkey, on April 14, 2021. Turkey confirmed 62,797 more novel coronavirus cases on Wednesday, its highest single-day figure since the start of the pandemic. Among the new cases are 2,802 symptomatic patients, and the total number in the country has reached 4,025,557, according to the Turkish Health Ministry. (Photo by Xinhua) TURKEY-ANKARA-COVID-19-CASES MustafaxKaya

Choose your license

Rights Managed:

One-time editorial use in an online article, social media channels, internal presentation, website, newsletter, or blog.

One-time editorial use in a book, newspaper or magazine (excluding cover page), external presentation. Limited to 5,000 circulation. This includes the rights available in the Standard license.

Media Info

Credit: Xinhua

Media ID:

Recording Date: Feb 16, 2021

Media Size: 3,000×2,000 Pixels

(210414) -- ANKARA, April 14, 2021 -- A woman receives the COVID-19 vaccine in Ankara, Turkey, on April 14, 2021. Turkey confirmed 62,797 more novel coronavirus cases on Wednesday, its highest single-day figure since the start of the pandemic. Among the new cases are 2,802 symptomatic patients, and the total number in the country has reached 4,025,557, according to the Turkish Health Ministry. (Photo by Xinhua) TURKEY-ANKARA-COVID-19-CASES MustafaxKaya

Restrictions: This image can not be published in China.

Release Info: Do I need a release?

Captions may have been translated or enriched by an AI system.
For more information about AI-assisted captions, see AI-assisted captions.

Need a custom license?

If your intended use isn't covered by the available options (such as non-editorial purposes or specific distribution needs), contact us. Our team will be happy to provide a tailored offer based on your requirements.